NeuralDrive develops medical devices that use neurostimulation therapy to help patients recover movement after spinal cord injuries. Their technology aims to restore motor function and improve quality of life for individuals with paralysis.
Funding
Funding not disclosed
Founders
Product
Problem
Spinal cord injuries often result in impaired motor function, significantly impacting patients' mobility and quality of life. Current rehabilitation methods may not fully restore voluntary movement, leaving many individuals with persistent deficits. The high lifetime healthcare costs associated with spinal cord injuries further underscore the need for more effective recovery solutions.
Solution
NeuralDrive develops a neurostimulation system designed to improve motor function recovery in individuals with spinal cord injuries. Their technology uses a neural interface with a microchip implanted in the motor cortex to deliver personalized cortical stimulation during motor training. By capturing the drive of an attempted movement and relaying a motor stimulus back to the microchip, the system creates a cyclical feedback loop that enhances movement execution. This approach aims to leverage neuroplasticity, enabling users to regain voluntary control of leg movement even after the stimulation has been turned off, ultimately fostering functional recovery.
Target Audience
The primary target audience includes clinicians specializing in spinal cord injury rehabilitation and individuals with paraplegia or tetraplegia seeking to improve their motor function and mobility.
Features
- Neural interface with implanted microchip for targeted motor cortex stimulation
- Neurostimulation optimization module for personalized cortical stimulation
- Cyclical feedback loop capturing attempted movement and relaying motor stimulus
- Real-time adjustment of stimulation parameters based on user's unique characteristics
- Designed for users with incomplete motor actions to maximize functional return through rehabilitation therapy